These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21692067)

  • 41. Undertreatment of High-Risk Localized Prostate Cancer in the California Latino Population.
    Lichtensztajn DY; Leppert JT; Brooks JD; Shah SA; Sieh W; Chung BI; Gomez SL; Cheng I
    J Natl Compr Canc Netw; 2018 Nov; 16(11):1353-1360. PubMed ID: 30442735
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of type of definitive treatment on race-based differences in prostate cancer-specific survival.
    Frego N; Labban M; Stone BV; Koelker M; Alkhatib K; Lughezzani G; Buffi NM; Lipsitz SR; Weissman JS; Fletcher SA; Kibel AS; Trinh QD; Cole AP
    Prostate; 2023 Aug; 83(11):1099-1111. PubMed ID: 37150867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Racial/ethnic differences in the relative risk of receipt of specific treatment among men with prostate cancer.
    Moses KA; Orom H; Brasel A; Gaddy J; Underwood W
    Urol Oncol; 2016 Sep; 34(9):415.e7-415.e12. PubMed ID: 27161898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.
    Powell IJ; Bock CH; Ruterbusch JJ; Sakr W
    J Urol; 2010 May; 183(5):1792-6. PubMed ID: 20299055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States).
    Cohen JH; Schoenbach VJ; Kaufman JS; Talcott JA; Schenck AP; Peacock S; Symons M; Amamoo MA; Carpenter WR; Godley PA
    Cancer Causes Control; 2006 Aug; 17(6):803-11. PubMed ID: 16783608
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disparities in the use of radiation therapy in patients with local-regionally advanced breast cancer.
    Martinez SR; Beal SH; Chen SL; Canter RJ; Khatri VP; Chen A; Bold RJ
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):787-92. PubMed ID: 20619550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study.
    Tyson MD; Alvarez J; Koyama T; Hoffman KE; Resnick MJ; Wu XC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Paddock LE; Stroup A; Chen VW; Penson DF; Barocas DA
    Eur Urol; 2017 Aug; 72(2):307-314. PubMed ID: 27816300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of Prostate Cancer Treatment Among Black and White Patients During the COVID-19 Pandemic.
    Bernstein AN; Talwar R; Handorf E; Syed K; Danella J; Ginzburg S; Belkoff L; Reese AC; Tomaszewski J; Trabulsi E; Singer EA; Jacobs B; Kutikov A; Uzzo R; Raman JD; Guzzo T; Smaldone MC; Correa A
    JAMA Oncol; 2021 Oct; 7(10):1467-1473. PubMed ID: 34292311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of distance to a urologist on early diagnosis of prostate cancer among black and white patients.
    Holmes JA; Carpenter WR; Wu Y; Hendrix LH; Peacock S; Massing M; Schenck AP; Meyer AM; Diao K; Wheeler SB; Godley PA; Stitzenberg KB; Chen RC
    J Urol; 2012 Mar; 187(3):883-8. PubMed ID: 22248516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thirty-day readmission rates for Medicare beneficiaries by race and site of care.
    Joynt KE; Orav EJ; Jha AK
    JAMA; 2011 Feb; 305(7):675-81. PubMed ID: 21325183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. African-American Men with Low-Risk Prostate Cancer: Modern Treatment and Outcome Trends.
    Obirieze AC; Moten A; Allen D; Ahaghotu CA
    J Racial Ethn Health Disparities; 2015 Sep; 2(3):295-302. PubMed ID: 26863460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment for older prostate cancer patients: disparities in a southern state.
    Pisu M; Oliver JS; Kim YI; Elder K; Martin M; Richardson LC
    Med Care; 2010 Oct; 48(10):915-22. PubMed ID: 20733530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Marriage and ethnicity predict treatment in localized prostate carcinoma.
    Denberg TD; Beaty BL; Kim FJ; Steiner JF
    Cancer; 2005 May; 103(9):1819-25. PubMed ID: 15795905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018.
    Parikh RB; Robinson KW; Chhatre S; Medvedeva E; Cashy JP; Veera S; Bauml JM; Fojo T; Navathe AS; Malkowicz SB; Mamtani R; Jayadevappa R
    JAMA Netw Open; 2020 Sep; 3(9):e2018318. PubMed ID: 32986109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trends in the Use of Stereotactic Body Radiotherapy for Treatment of Prostate Cancer in the United States.
    Mahase SS; D'Angelo D; Kang J; Hu JC; Barbieri CE; Nagar H
    JAMA Netw Open; 2020 Feb; 3(2):e1920471. PubMed ID: 32022878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Racial differences in surgeons and hospitals for endometrial cancer treatment.
    Armstrong K; Randall TC; Polsky D; Moye E; Silber JH
    Med Care; 2011 Feb; 49(2):207-14. PubMed ID: 21150796
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ultraviolet index and racial differences in prostate cancer incidence and mortality.
    Taksler GB; Cutler DM; Giovannucci E; Smith MR; Keating NL
    Cancer; 2013 Sep; 119(17):3195-203. PubMed ID: 23744754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigating racial differences in clinical and pathological features of prostate cancer in South African men.
    Dewar M; Kaestner L; Zikhali Q; Jehle K; Sinha S; Lazarus J
    S Afr J Surg; 2018 Jun; 56(2):54-58. PubMed ID: 30010267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Residual treatment disparities after oncology referral for rectal cancer.
    Morris AM; Billingsley KG; Hayanga AJ; Matthews B; Baldwin LM; Birkmeyer JD
    J Natl Cancer Inst; 2008 May; 100(10):738-44. PubMed ID: 18477800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial.
    Miller EA; Pinsky PF; Black A; Andriole GL; Pierre-Victor D
    Prostate; 2018 Aug; 78(11):830-838. PubMed ID: 29667217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.